Prevalence of G6PD deficiency in a large cohort of HIV-infected patients

Journal of Infection

Volumn 61, Issue 5, 2010, Pages 399-402

  Serpa, Jose A ^a   Villarreal Williams, Erick ^a   Giordano, Thomas P ^a,b  

^a HARRIS COUNTY HOSPITAL DISTRICT   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

G6PD deficiency; Hemolytic anemia; HIV

Indexed keywords

COTRIMOXAZOLE; DAPSONE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; HEMOGLOBIN;

ADULT; AFRICAN AMERICAN; ARTICLE; COHORT ANALYSIS; FEMALE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HEMOGLOBIN DETERMINATION; HEMOLYTIC ANEMIA; HIGH RISK POPULATION; HISPANIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE;

ADULT; AFRICAN AMERICANS; AGED; ANEMIA, HEMOLYTIC; ANTI-INFECTIVE AGENTS; COHORT STUDIES; DAPSONE; DRUG COMBINATIONS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUCOSEPHOSPHATE DEHYDROGENASE DEFICIENCY; HISPANIC AMERICANS; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PREVALENCE; SULFAMETHIZOLE; TEXAS; TRIMETHOPRIM; URBAN POPULATION; YOUNG ADULT;

EID: 78149359286     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2010.08.003     Document Type: Article

References (9)

1. Cappellini M.D., Fiorelli G. Glucose-6-phosphate dehydrogenase deficiency. Lancet 2008, 371(9606):64-74.
2. Nkhoma E.T., Poole C., Vannappagari V., Hall S.A., Beutler E. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 2009, 42(3):267-278.
3. Rapezzi D., Porqueddu E.M., Fenu L., Racchi O., Ferraris A.M., Gaetani G.F., et al. Survival of people who are HIV-1-positive and G6PD-deficient is unaffected by virus-induced oxidative stress. Lancet 1998, 351:264-265.
4. Tungsiripat M., Drechsler H., Sarlone C., Amyot K., Laffey E., Aberg J. Prevalence and significance of G6PD deficiency in patients of an urban HIV clinic. J Int Assoc Physicians AIDS Care (Chic Ill) 2008, 7(2):88-90.
5. Aberg J.A., Kaplan J.E., Libman H., Emmanuel P., Anderson J.R., Stone V.E., et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 2009, 49(5):651-681.
6. Minucci A., Giardina B., Zuppi C., Capoluongo E. Glucose-6-phosphate dehydrogenase laboratory assay: how, when, and why?. IUBMB Life 2009, 61(1):27-34.
7. Petrakis N.L., Wiesenfeld S.L., Sams B.J., Collen M.F., Cutler J.L., Siegelaub A.B. Prevalence of sickle-cell trait and glucose-6-phosphate dehydrogenase deficiency. N Engl J Med 1970, 282(14):767-770.
8. Chinevere T.D., Murray C.K., Grant E., Johnson G.A., Duelm F., Hospenthal D.R. Prevalence of glucose-6-phosphate dehydrogenase deficiency in U.S. Army personnel. Mil Med 2006, 171(9):905-907.
9. Kaplan J.E., Benson C., Holmes K.H., Brooks J.T., Pau A., Masur H. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009, 58(RR-4):1-207.